News

US relaxes its guidelines on herbal supplements

BMJ 2000; 320 doi: 10.1136/bmj.320.7229.207/a (Published 22 January 2000)
Cite this as: BMJ 2000;320:207.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Scott Gottlieb
  1. New York

    The US Food and Drug Administration (FDA) has relaxed guidelines for the sale of herbal supplements. Its decision has opened the way for manufacturers of vitamins, herbs, and dietary supplements to market their products for conditions such as morning sickness, hot flushes, and memory loss in ageing without first proving that they are safe or effective.

    The decision marks the latest …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular